Gene Mack

Gene Mack

Chief Executive OfficeratGain Therapeutics· In proxies 2023–2025

Pay in FY2025+99% from the year before · Gain Therapeutics stock +49.1% the same year

Gene Mack was paid $1.5M in FY2025 (Dec), up 99%. Gain Therapeutics stock rose 49.1% that year.

Pay$100 in the stock at the end of FY22 → $103
Pay is from the Summary Compensation Table of each Gain Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Gain TherapeuticsPublic company · 3 yr
    • Chief Executive Officer2023 – Present · 3 yrStock in role -60%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?